Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIOSU

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOSU
DateTimeSourceHeadlineSymbolCompany
10/16/20234:15PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BIOSUBioPlus Acquisition Corporation
10/04/20237:39AMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BIOSUBioPlus Acquisition Corporation
10/04/20237:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOSUBioPlus Acquisition Corporation
10/04/20237:30AMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSUBioPlus Acquisition Corporation
09/15/20234:00PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
08/16/20239:01AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
08/14/20234:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOSUBioPlus Acquisition Corporation
07/17/20238:01AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
06/14/20236:09AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
06/14/20236:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/30/20234:04PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/19/20234:50PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/19/20234:05PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/15/20234:29PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/15/20236:38AMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/12/20234:17PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/03/20238:47AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/03/20238:44AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
04/27/20234:35PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/14/20233:39PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/02/202310:10AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSUBioPlus Acquisition Corporation
11/03/20225:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
10/11/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
08/10/20224:33PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
05/12/20224:55PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/11/20224:05PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
02/09/20222:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/06/20218:00AMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
12/02/20218:55PMGlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOSU